N -(Anthrancen-9-ylmethyl) isoserines are useful drug intermediates but short for efficient synthesis. We herein report the synthesis of N -(anthrancen-9-ylmethyl) isoserines via a Rh 2 (Ph 3 COO) 3 (OAc) and chiral phosphoric acid (CPA) synergistically catalyzed multicomponent reaction (MCR) of N -alkyl imines, alcohols, and diazoesters. The method representing the first example of N -alkyl imines-involved MCR is featured by high atom-economy, high diastereo- and enantioselectivities, and broad substrate scope. DFT calculations on the mechanism of the MCR reveals that the hydrophobic interactions and π–π stackings between N -(anthrancen-9-ylmethyl) imines and Rh 2 (Ph 3 COO) 3 (OAc)/CPA cocatalyst is essential to the reactivity and stereocontrol. The synthetic applications of the MCR products include the semisynthesis of paclitaxel, its alkyne-tagged derivative, and β -lactam as an anticancer agent overcoming paclitaxel-resistance. We expect this work to shed light on the development of new N -alkyl imines-involved reactions and on the synthesis of drugs with isoserines as intermediates.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: